About Us

About Gaea CRO

Today, Gaea is headquartered in Tallinn, Estonia, one of the world’s most advanced digital societies. Our experienced, low-turnover team uses industry-standard systems, including Veeva Vault, to provide efficient, transparent, and fully compliant clinical development support.

Our expertise lies in complex hospital-based studies and indications where operational excellence is often the difference between success and failure. This includes renal, critical care, respiratory diseases, neurology, dermatology, oncology and all phases of clinical development.

Critical care remains one of the most demanding areas of clinical development. Intensive care units operate 24/7, generate large volumes of data, and require research teams capable of working effectively in a fast-moving environment.

Unlike many CEOs, I remain actively involved in every sponsor programme. My role is to support our teams, challenge assumptions, mitigate risks early, and help ensure studies are delivered on time, within budget, and with quality at their core.

We combine the expertise of a large CRO with the agility, responsiveness, and senior-level attention of a specialist partner.

Therapeutic Areas

Gaea has extensive experience managing clinical trials for investigational medicinal products across a broad range of therapeutic areas, including:

• Respiratory diseases, including COPD, hospital viral infections and community-acquired pneumonia (CAP).
• Critical care conditions, including acute respiratory distress syndrome (ARDS), sepsis, and septic shock.
• Oncology, spanning a range of solid tumours and haematological malignancies.
• Nephrology, end-stage kidney disease with peritoneal dialysis.
• Dermatology.

Our team has particular expertise in phases 0, 1 and 2, and delivering studies in challenging clinical environments such as intensive care units (ICUs).